Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.58661 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.57063 | 25 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.57187 | 25 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.50784 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.51985 | 24 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.63288 | 24 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.59518 | 24 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.0001 | 44 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.52706 | 24 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.56114 | 25 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.5528 | 24 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.53144 | 24 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.55533 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.56147 | 24 |